Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Array BioPharma Inc.
DescriptionDual p38 mitogen-activated protein kinase (p38 MAPK; MAPK14) and tyrosine kinase receptor 2 (Tie2) inhibitor
Molecular Target p38 mitogen-activated protein kinase (p38 MAPK) (MAPK14) ; Tyrosine kinase receptor 2 (Tie2)
Mechanism of ActionMAP kinase (p38) inhibitor; Tyrosine kinase receptor 2 (Tie2) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationMyelodysplastic syndrome (MDS)
Indication DetailsTreat myelodysplastic syndrome (MDS)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today